Page 21 - Vaccine

Over 118 crore Covid vaccine doses administered in India so far: Govt

The next phase of Covid-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions

Over 117 crore Covid vaccine doses administered in India: Govt

The country launched vaccination for all people aged above 45 years from April 1

India-made Covid-19 vaccine Covaxin now on UK's approved travel list

Earlier this month, the Bharat Biotech manufactured Covaxin had received its WHO EUL status

Vaccine exports will grow with rise in production of Covid shots: PM Modi

WHO setting up Global Centre for traditional medicines in India

Health regulatory agencies likely to come under DCGI ambit

Single-window system to take care of regulatory need for drugs, vaccines

Lessons from Europe

India must speed up vaccination

Explained: What it takes to run child trials for a Covid-19 vaccine

JAB AT HAND: From encouraging people to volunteer to screening kids and winning their confidence

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab

A big boost

Covaxin gets the stamp of international legitimacy

PM holds meeting with DMs of over 40 districts on low Covid vaccination

The central government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country, the ministry said.

India's Covid-19 vaccination coverage crosses 102.8 crore-mark, says govt

More than 58 lakh (58,87,981) vaccine doses have been administered till 7 pm on Monday

Biological E's protein sub-unit vaccine roll out likely in November

Firm plans to make a billion annual doses of the vaccine apart from 600 million J&J doses a year

A billion Covid-19 vaccine doses, festivals to rev up economy: PM Modi

The one-billion mark for vaccines has given a ray of hope for small businesses, hawkers and vendors, Modi said

Vax milestone and a K-shaped problem

Lower-income groups will be far more vulnerable in the Third Wave, whenever that arrives

1 billion doses: How India's Covid vaccine campaign compares to others

Most populous states may decide pace going forward

Vaccine makers meet WTO D-G, flag excess capacity of Covid-19 jabs

Some manufacturers also said that the regulatory approval framework for Covid-19 vaccines in other nations also takes a substantial amount of time

The next level

Vaccination programme still has a long way to go

Vaccine working on new variants next challenge: SII CEO Adar Poonawalla

'We are delivering 220 million doses a month, and almost everything is being consumed', said Poonawalla

Covid-19 pandemic: Vaccinating children not a priority for now, say experts

They say mRNA vaccines could offer best protection for vulnerable children

How Gennova is developing India's first indigenous mRNA Covid-19 shot

Where Gennova scores is that it has achieved to crack the stringent sub-zero temperature requirements